Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques

Journal of Mass Spectrometry

Volumn 47, Issue 1, 2012, Pages 54-65

  Hutter, M ^a   Broecker, S ^b   Kneisel, S ^a   Auwarter V ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

aminoalkylindoles; JWH; LC MS MS; metabolism; synthetic cannabinoids

Indexed keywords

ACCURATE MASS; ALKYL CHAIN; AMINOALKYLINDOLES; CANNABINOIDS; DRUG TESTING; HERBAL MIXTURES; INDOLE MOIETY; JWH; LC-MS/MS; METABOLIC PATHWAYS; PRODUCT ION SPECTRA; SCREENING METHODS; SIDE-CHAINS; URINARY METABOLITES; URINE SAMPLE;

BIOMOLECULES; BODY FLUIDS; METABOLITES; NAPHTHALENE; SPICE;

METABOLISM;

3 (1 NAPHTHOYL) 1 PENTYLINDOLE; AMINOALKYLINDOLE; CANNABINOID; DRUG METABOLITE; INDOLE DERIVATIVE; JWH 073; JWH 081; JWH 122; JWH 210; JWH 250; NAPHTHALENE; RCS 4; SYNTHETIC CANNABINOID; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CARBOXYLATION; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HYDROXYLATION; LIQUID CHROMATOGRAPHY; MONOHYDROXYLATION; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; URINALYSIS;

CANNABINOIDS; CHROMATOGRAPHY, LIQUID; HUMANS; INDOLES; IONS; STREET DRUGS; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 84856349177     PISSN: 10765174     EISSN: 10969888     Source Type: Journal    
DOI: 10.1002/jms.2026     Document Type: Article

References (26)

1. J. W. Huffman, G. Zengin, M. J. Wu, J. Lu, G. Hynd, K. Bushell, A. L. Thompson, S. Bushell, C. Tartal, D. P. Hurst, P. H. Reggio, D. E. Selley, M. P. Cassidy, J. L. Wiley, B. R. Martin,. Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists. Bioorg. Med. Chem. 2005, 13, 89.
2. M. M. Aung, G. Griffin, J. W. Huffman, M. Wu, C. Keel, B. Yang, V. M. Showalter, M. E. Abood, B. R. Martin,. Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding. Drug Alcohol Depend. 2000, 60, 133.
3. K. S. Marriott, J. W. Huffman,. Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor. Curr. Top. Med. Chem. 2008, 8, 187.
4. B. K. Atwood, J. Huffman, A. Straiker, K. Mackie,. JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist. Br. J. Pharmacol. 2010, 160, 585.
5. J. W. Huffman, L. W. Padgett,. Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes. Curr. Med. Chem. 2005, 12, 1395.
6. V. M. Showalter, D. R. Compton, B. R. Martin, M. E. Abood,. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther. 1996, 278, 989.
7. Synthetic cannabinoids in herbal products, UNODC, SCITEC/24, April 2011.
8. R. Lindigkeit, A. Boehme, I. Eiserloh, M. Luebbecke, M. Wiggermann, L. Ernst, T. Beuerle,. Spice: a never ending story? Forensic Sci. Int. 2009, 191, 58.
9. V. Auwärter, S. Dresen, W. Weinmann, M. Müller, M. Pütz, N. Ferreirõs,. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J. Mass Spectrom. 2009, 44, 832.
10. N. Uchiyama, R. Kikura-Hanajiri, N. Kawahara, Y. Haishima, Y. Goda,. Identification of a cannabinoid analog as a new type of designer drug in a herbal product. Chem. Pharm. Bull.(Tokyo) 2009, 57, 439.
11. S. Dresen, N. Ferreirõs, M. Pütz, F. Westphal, R. Zimmermann, V. Auwärter,. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. J. Mass Spectrom. 2010, 45, 1186.
12. N. Uchiyama, R. Kikura-Hanajiri, J. Ogata, Y. Goda,. Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Sci. Int. 2010, 198, 31.
13. F. Westphal, T. Junge, F. Sönnichsen, P. Rösner, J. Schäper, Ein neuer Wirkstoff in Spice-artigen Kräutermischungen: Charakterisierung von JWH-250, seinen Methyl- und Trimethylsilylderivaten. Toxichem Krimtech 2010, 77, 8.
14. L. Ernst, H. M. Schiebel, C. Theuring, R. Lindigkeit, T. Beuerle,. Identification and characterization of JWH-122 used as new ingredient in "Spice-like" herbal incenses. Forensic Sci. Int. 2011, 208, e31.
15. S. Dresen, S. Kneisel, W. Weinmann, R. Zimmermann, V. Auwärter,. Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. J. Mass Spectrom. 2011, 46, 163.
16. J. Teske, J. P. Weller, A. Fieguth, T. Rothämel, Y. Schulz, H. D. Tröger,. Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2010, 878, 2659.
17. Q. Zhang, P. Ma, R. B. Cole, G. Wang,. Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS. Anal. Bioanal. Chem. 2006, 386, 1345.
18. A. Wintermeyer, I. Möller, M. Thevis, M. Jübner, J. Beike, M. A. Rothschild, K. Bender,. In vitro phase I metabolism of the synthetic cannabimimetic JWH-018. Anal. Bioanal. Chem. 2010, 398, 2141.
19. T. Sobolevsky, I. Prasolov, G. Rodchenkov,. Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Sci. Int. 2010, 200, 141.
20. I. Möller, A. Wintermeyer, K. Bender, M. Jübner, A. Thomas, O. Krug, W. Schänzer, M. Thevis,. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. Drug Test. Anal. 2010, 3, 609
21. D. K. Wissenbach, M. R. Meyer, D. Remane, A. A. Philipp, A. A. Weber, H. H. Maurer,. Drugs of abuse screening in urine as part of a metabolite-based LC-MS(n) screening concept. Anal. Bioanal. Chem. 2011, 400, 3481.
22. S. Beuck, I. Möller, A. Thomas, A. Klose, N. Schlörer, W. Schänzer, M. Thevis,. Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing. Anal. Bioanal. Chem. 2011, 401, 493.
23. A. Grigoryev, S. Savchuk, A. Melnik, N. Moskaleva, J. Dzhurko, M. Ershov, A. Nosyrev, A. Vedenin, B. Izotov, I. Zabirova, V. Rozhanets,. Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2011, 879, 1126.
24. C. L. Moran, V. H. Le, K. C. Chimalakonda, A. L. Smedley, F. D. Lackey, S. N. Owen, P. D. Kennedy, G. W. Endres, F. L. Ciske, J. B. Kramer, A. M. Kornilov, L. D. Bratton, P. J. Dobrowolski, W. D. Wessinger, W. E. Fantegrossi, P. L. Prather, L. P. James, A. Radominska-Pandya, J. H. Moran,. Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine. Anal. Chem. 2011, 83, 4228.
25. S. Hudson, J. Ramsey, L. King, S. Timbers, S. Maynard, P. I. Dargan, D. M. Wood,. Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products. J. Anal. Toxicol. 2010, 34, 252.
26. L. K. Brents, E. E. Reichard, S. M. Zimmerman, J. H. Moran, W. E. Fantegrossi, P. L. Prather,. Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. PLoS One 2011, 6, e21917.